Rotavac

As India’s population grows, its need for adequate pharmaceutical and medical infrastructure is also going to burgeon. In such a scenario, it is important to give equal attention to research into rare diseases and their cures. Dr. Namitha Kumar takes a closer look at India’s research progress in this field, and what still needs to be done going forward.

In India, the deadly rotavirus diarrhea causes nearly 1,00,000 deaths among children. The vaccination campaign launched this March aims to curb these deaths.

PM Narendra Modi has launched India's first home-grown Rotavirus vaccine, at a price point of Rs. 63. This makes it the cheapest Rotavirus vaccine globally, and is expected to bring down the high number of deaths caused by the virus in India and around the world.